Seizert Capital Partners, LLC Organon & Co. Transaction History

Seizert Capital Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$16.59 - $23.77 $71,552 - $102,520	4,313 Added 1.52%	288,046 $5 Million
Q2 2023 Jul 27, 2023	SELL	$19.27 - $24.63 $69,372 - $88,668	-3,600 Reduced 1.25%	283,733 $5.9 Million
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $385,774 - $577,760	18,010 Added 6.69%	287,333 $6.76 Million
Q4 2022 Jan 30, 2023	SELL	$23.31 - $28.61 $3.77 Million - $4.63 Million	-161,696 Reduced 37.51%	269,323 $7.52 Million
Q3 2022 Nov 02, 2022	SELL	$23.4 - $34.25 $380,998 - $557,658	-16,282 Reduced 3.64%	431,019 $10.1 Million
Q2 2022 Aug 04, 2022	BUY	$31.66 - $38.9 $1.63 Million - $2 Million	51,436 Added 12.99%	447,301 $15.1 Million
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $2.21 Million - $2.86 Million	-72,583 Reduced 15.49%	395,865 $13.8 Million
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $1.74 Million - $2.25 Million	-60,688 Reduced 11.47%	468,448 $14.3 Million
Q3 2021 Nov 03, 2021	BUY	$28.63 - $35.64 $15.1 Million - $18.9 Million	529,136 New	529,136 $17.4 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.